Jump to Content


Sleep apnea affects around 10% of the adult population globally, which makes it the fourth most expensive disease after cancer, diabetes and coronary heart disease. However, about 80-90% of individuals with sleep apnea are undiagnosed.  If left untreated, sleep apnea is linked to higher risks of developing cardiovascular disorders and stroke as well as higher rates of car accidents.

The traditional clinical practice in sleep monitoring is the full-night supervised in-laboratory assessment. This method is costly and inconvenient. Furthermore, home monitoring tests on the market require the individual to wear a mask on their face while asleep.

We plan to tackle these barriers by further developing BresoTec Inc.’s SOUND Sleep into a portable, non-contact monitoring system that is capable of detecting sleep apnea without any inconvenience to the patient.

uhn logo
bresotec logo
university-of-toronto logo

Solution Type